KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Assets Average (2016 - 2025)

Eli Lilly's Assets Average history spans 17 years, with the latest figure at $113.7 billion for Q4 2025.

  • For Q4 2025, Assets Average rose 47.36% year-over-year to $113.7 billion; the TTM value through Dec 2025 reached $113.7 billion, up 47.36%, while the annual FY2025 figure was $95.6 billion, 33.96% up from the prior year.
  • Assets Average reached $113.7 billion in Q4 2025 per LLY's latest filing, up from $107.9 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $113.7 billion in Q4 2025 to a low of $46.7 billion in Q1 2021.
  • Average Assets Average over 5 years is $64.4 billion, with a median of $55.2 billion recorded in 2023.
  • Peak YoY movement for Assets Average: fell 1.53% in 2022, then soared 47.36% in 2025.
  • A 5-year view of Assets Average shows it stood at $48.5 billion in 2021, then dropped by 0.04% to $48.5 billion in 2022, then grew by 25.76% to $61.0 billion in 2023, then rose by 26.57% to $77.2 billion in 2024, then surged by 47.36% to $113.7 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Assets Average are $113.7 billion (Q4 2025), $107.9 billion (Q3 2025), and $95.2 billion (Q2 2025).